Literature DB >> 7931619

Influence of major depression on 1-year outcome in patients with traumatic brain injury.

R E Jorge1, R G Robinson, S E Starkstein, S V Arndt.   

Abstract

The authors examine those factors that contributed to deterioration in social functioning, activities of daily living, or intellectual functioning during a 1-year period after traumatic brain injury (TBI). Fifty-two patients suffering an acute TBI were evaluated for existence and severity of mood disorders and impairment during their hospital stays and at 3-, 6-, and 12-month follow-up examinations. Patients whose scores on intellectual function, social function, or daily activities deteriorated during the 1-year period after trauma were considered to have a poor outcome. Eleven of 52 patients had a poor outcome in social function, which was associated with race, right-hemisphere lesions, intellectual impairment, and prolonged major depression. Seven of 52 patients had a poor outcome in daily activities, which was associated with a major depression of more than 6 months' duration and severity of Hamilton Depression Rating Scale scores. Eleven of these patients had a poor outcome in cognitive function, which was associated with cognitive impairment immediately after TBI. A major depression lasting more than 6 months was associated with deterioration of social functioning and activities of daily living during the 1-year period after TBI.

Entities:  

Mesh:

Year:  1994        PMID: 7931619     DOI: 10.3171/jns.1994.81.5.0726

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

1.  Employment retention after moderate-severe traumatic brain injury (TBI) in the British Army 1989-98.

Authors:  A McLeod; A Wills; J Etherington
Journal:  Occup Environ Med       Date:  2004-05       Impact factor: 4.402

2.  Depression among older adults after traumatic brain injury: a national analysis.

Authors:  Jennifer S Albrecht; Zippora Kiptanui; Yuen Tsang; Bilal Khokhar; Xinggang Liu; Linda Simoni-Wastila; Ilene H Zuckerman
Journal:  Am J Geriatr Psychiatry       Date:  2014-07-26       Impact factor: 4.105

3.  Risk Factors for New-Onset Depression After First-Time Traumatic Brain Injury.

Authors:  Durga Roy; Vassilis Koliatsos; Sandeep Vaishnavi; Dingfen Han; Vani Rao
Journal:  Psychosomatics       Date:  2017-07-20       Impact factor: 2.386

Review 4.  Depression following traumatic brain injury: epidemiology, risk factors and management.

Authors:  Mark J Rapoport
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

Review 5.  Management of psychiatric and neurological comorbidities in epilepsy.

Authors:  Andres M Kanner
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

6.  Patterns of Depression Treatment in Medicare Beneficiaries with Depression after Traumatic Brain Injury.

Authors:  Jennifer S Albrecht; Zippora Kiptanui; Yuen Tsang; Bilal Khokhar; Gordon S Smith; Ilene H Zuckerman; Linda Simoni-Wastila
Journal:  J Neurotrauma       Date:  2015-03-25       Impact factor: 5.269

7.  Effect of brain tumour laterality on patients' perceived quality of life.

Authors:  J Salo; A Niemelä; M Joukamaa; J Koivukangas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

8.  Depression Trajectories during the First Year after Traumatic Brain Injury.

Authors:  Charles H Bombardier; Trynke Hoekstra; Sureyya Dikmen; Jesse R Fann
Journal:  J Neurotrauma       Date:  2016-05-06       Impact factor: 5.269

9.  Safety of Antidepressant Classes Used Following Traumatic Brain Injury Among Medicare Beneficiaries: A Retrospective Cohort Study.

Authors:  Jennifer S Albrecht; Vani Rao; Eleanor M Perfetto; C Daniel Mullins
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

10.  Brief report of affective state and depression status after traumatic brain injury.

Authors:  Shannon B Juengst; Patricia M Arenth; Ellen M Whyte; Elizabeth R Skidmore
Journal:  Rehabil Psychol       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.